{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:18:35Z","timestamp":1784801915527,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jceh.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T05:01:18Z","timestamp":1507093278000},"page":"275-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"given":"Ashish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrihari A.","family":"Anikhindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-276X","authenticated-orcid":false,"given":"Ritesh","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2017.09.003_bib0165","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jceh.2017.09.003_bib0170","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jceh.2017.09.003_bib0175","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions. http:\/\/handbook.cochrane.org\/ Accessed 25.04.16."},{"key":"10.1016\/j.jceh.2017.09.003_bib0180","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.jceh.2017.09.003_bib0185","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM198710013171403","article-title":"Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices","volume":"317","author":"Pascal","year":"1987","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.1840080103","article-title":"Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study","volume":"8","author":"Id\u00e9o","year":"1988","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0168-8278(88)80515-4","article-title":"Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial","volume":"7","author":"Lebrec","year":"1988","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0168-8278(89)90078-0","article-title":"Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding","volume":"9","year":"1989","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jceh.2017.09.003_bib0205","first-page":"1016","article-title":"Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The PROVA Study Group","volume":"14","year":"1991","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.jceh.2017.09.003_bib0210","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-012-9353-8","article-title":"Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial","volume":"7","author":"Sarin","year":"2013","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.jceh.2017.09.003_bib0220","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis","volume":"127","author":"Merkel","year":"2004","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jceh.2017.09.003_bib0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension","volume":"11","author":"Cal\u00e9s","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jceh.2017.09.003_bib0230","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.1840120624","article-title":"Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo","volume":"12","author":"Andreani","year":"1990","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jceh.2017.09.003_bib0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hep.1840130517","article-title":"Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group","volume":"13","author":"Conn","year":"1991","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jceh.2017.09.003_bib0240","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach","volume":"19","author":"D\u2019Amico","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.jceh.2017.09.003_bib0245","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2017.09.003_bib0250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1572-0241.2000.01775.x","article-title":"Natural history of cirrhotic patients with small esophageal varices: a prospective study","volume":"95","author":"Zoli","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jceh.2017.09.003_bib0255","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/gut.31.11.1298","article-title":"Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding","volume":"31","author":"Cal\u00e8s","year":"1990","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jceh.2017.09.003_bib0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12072-008-9096-8","article-title":"Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver","volume":"2","author":"Sarin","year":"2008","journal-title":"Hepatol Int"},{"issue":"8187","key":"10.1016\/j.jceh.2017.09.003_bib0265","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(80)90063-X","article-title":"Propranolol \u2013 a medical treatment for portal hypertension?","volume":"2","author":"Lebrec","year":"1980","journal-title":"Lancet"},{"issue":"8708","key":"10.1016\/j.jceh.2017.09.003_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0140-6736(90)91668-Z","article-title":"Meta-analysis of value of propranolol in prevention of variceal haemorrhage","volume":"336","author":"Hayes","year":"1990","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jceh.2017.09.003_bib0275","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","volume":"324","author":"Poynard","year":"1991","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jceh.2017.09.003_bib0280","first-page":"408","article-title":"Beta-blockers for the prevention of variceal haemorrhage in patients with cirrhosis: an updated meta-analysis of randomized controlled trials","volume":"23","author":"Ricca Rosellini","year":"1991","journal-title":"Ital J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-117-1-59","article-title":"Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment","volume":"117","author":"Pagliaro","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0290","first-page":"63","article-title":"Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis","volume":"25","author":"Bernard","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2017.09.003_bib0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-149-2-200807150-00007","article-title":"Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis","volume":"149","author":"Gonzalez","year":"2008","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.jceh.2017.09.003_bib0300","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3748\/wjg.15.2151","article-title":"Efficacy of beta-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: a meta-analysis","volume":"15","author":"Ding","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"47","key":"10.1016\/j.jceh.2017.09.003_bib0305","first-page":"5982","article-title":"Benefit of combination \u03b2-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis","volume":"16","author":"Funakoshi","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2017.09.003_bib0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncpgasthep0063","article-title":"Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?","volume":"2","author":"Bosch","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jceh.2017.09.003_bib0315","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jceh.2017.09.003_bib0320","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3748\/wjg.v21.i10.3100","article-title":"Nonselective beta-blockers in cirrhotic patients with no or small varices: a meta-analysis","volume":"21","author":"Qi","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688317304607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688317304607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:41Z","timestamp":1760853881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688317304607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0973688317304607"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2017.09.003","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 INASL.","name":"copyright","label":"Copyright"}]}}